Eczema drug shows promise for better sleep in kids
NCT ID NCT05042258
First seen May 01, 2026 · Last updated May 01, 2026
Summary
This study looks at whether dupilumab, a medication for moderate to severe eczema, can improve sleep and reduce itching in children aged 6 to 17. Over 12 weeks, researchers will measure sleep quality and itchiness before and after treatment. The goal is to see if the drug helps restore normal sleep patterns and eases discomfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lurie Children's Hospital/Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.